Legumain in cardiovascular diseases
Experimental Biology and Medicine · 2024
DOI: 10.3389/ebm.2024.10121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Lei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Cysteine Endopeptidases, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, having become a global public health problem, so the pathophysiological mechanisms and therapeutic strategies of CVDs need further study. Legumain is a powerful enzyme that is widely distributed in mammals and plays an important role in a variety of biological processes. Recent research suggests that legumain is associated with the occurrence and progression of CVDs. In this review, we provide a comprehensive overview of legumain in the pathogenesis of CVDs. The role of legumain in CVDs, such as carotid atherosclerosis, pulmonary hypertension, coronary artery disease, peripheral arterial disease, aortic aneurysms and dissection, is discussed. The potential applications of legumain as a biomarker of these diseases are also explored. By understanding the role of legumain in the pathogenesis of CVDs, we aim to support new therapeutic strategies to prevent or treat these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Institute of Clinical Medicine, National Science and Technology Key Infrastructure on Translational Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Acad…
Zitieren
APA
Zhou, L., Wu, J., Wei, Z., & Zheng, Y. (2024). Legumain in cardiovascular diseases. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10121
Vancouver
Zhou L, Wu J, Wei Z, Zheng Y. Legumain in cardiovascular diseases. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10121
BibTeX
@article{Zhou2024,
author = {Zhou, Lei and Wu, Jianqiang and Wei, Zairong and Zheng, Yuehong},
title = {Legumain in cardiovascular diseases},
journal = {Experimental Biology and Medicine},
year = {2024},
doi = {10.3389/ebm.2024.10121}
}
EUVIMED